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I read the article entitled “Maternal hyperglycemia and the 100-
g oral glucose tolerance test” [1] on gestational diabetes mellitus
(GDM) with interest. The last sentence in the conclusion, “Further
large-scale studies should continue to develop new diagnostic
criteria for GDM, including mild hyperglycemia, to improve preg-
nancy outcomes,” may be correct. However, the conclusion in the
abstract that GDMdiagnosed using the 100-g oral glucose tolerance
test (OGTT) is necessary for improving pregnancy outcomes is
rather confusing. The authors have cited the large multicenter,
multiethnic group study, published in 2008, on hyperglycemia
and adverse pregnancy outcome using a 75-g OGTT in the introduc-
tion; however, they have not mentioned any associated problems
involved in the adoption of the 75-g OGTT in the discussion. I would
like to summarize some of the recently updated views on this
aspect.
Firstly, I searched the most recent articles in the Cochrane Li-
brary Database. “There was insufﬁcient evidence to determine if
screening for gestational diabetes, or what types of screening,
can improve maternal and infant health outcomes” [2]. In another
study, the 75-g OGTT showed a higher relative risk for diagnosing
GDM (risk ratio 2.55, 95% conﬁdence interval 0.96e6.75) than the
100-g OGTT. However, the authors concluded that “the evidence is
insufﬁcient to permit assessment of which strategy is best for
diagnosing GDM” [3]. When comparing women receiving a diet
and exercise intervention with those receiving no intervention,
no clear difference in the risk of developing GDM was observed
(average risk ratio 0.92, 95% conﬁdence interval 0.68e1.23) [4].
The authors concluded that “the ability to draw ﬁrm conclusions
was limited by variations in the quality of trials, characteristics
of the interventions and populations assessed, and outcome deﬁ-
nitions between trials.” In addition, they identiﬁed an additional
16 ongoing trials and proposed to include them in the next update
of their review [4]. A meta-analysis of randomized studies
revealed that nutrition manipulation in pregnancy on the basis
of the diet or mixed approach did not appear to reduce the risk
of GDM. It was concluded that “nutritional supplements show po-
tential as agents for primary prevention of GDM” [5]. A new report
of a randomized trial among ethnically diverse pregnant women
at an increased risk of GDM showed that a prenatal exercise inter-
vention implemented in the second trimester did not result in a
statistically signiﬁcant reduction in the relative odds for GDM,
impaired glucose tolerance (IGT), or abnormal glucose screening
[6].
Secondly, we all know that the so-called traditional two-step
approach, i.e., screening pregnant women for GDM with a 50-g
oral glucose challenge test (OGCT) followed by a diagnostic testhttp://dx.doi.org/10.1016/j.tjog.2015.06.007
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used. However, experts of the International Association of Diabetes
and Pregnancy Study Groups (IADPSG) recommended the one-step
approach in 2010, i.e., diagnostic testing using only a 75-g 2-hour
OGTT, which was primarily based on the outcome data reported
in the hyperglycemia and adverse pregnancy outcome study. This
approach is considered more convenient, better tolerated, and
more sensitive for identifying pregnant women at risk for adverse
outcomes than the 100-g 3-hour OGTT, and it is becoming more
popular.
A retrospective cohort study involving all pregnant women
who underwent screening for GDM, between 2008 and 2011,
was conducted [7], in which the diagnosis of GDM was based
on universal screening using a 50-g OGCT (threshold 140 mg/
dL) and a diagnostic test using a fasting 2-hour, 75-g OGTT ac-
cording to the 2008 recommendations by the Canadian Diabetes
Association (CDA). The diagnosis of GDM required the presence
of two or more abnormal values, although a single abnormal
value was indicative of IGT. Because the OGTT threshold values
based on the IADPSG criteria are lower than the CDA 2008
thresholds, the authors concluded that using the IADPSG criteria
instead of the CDA criteria would result in a considerable in-
crease in the rate of GDM diagnosis; however, this also appeared
to identify additional women at a similar risk of adverse preg-
nancy outcomes [7]. Another study showed that women with
previous GDM based on the IADPSG criteria demonstrated a
greater than three-fold prevalence of metabolic syndrome than
women with normal glucose tolerance in pregnancy [8]. Never-
theless, identifying more pregnant women with GDM followed
by appropriate therapy or pregnant women with impaired or
even normal glucose tolerance followed by appropriate educa-
tion and intervention may decrease fetal and maternal morbidity,
particularly because of macrosomia, shoulder dystocia, and
preeclampsia.
At present, the American College of Obstetricians and Gyne-
cologists recommends a two-step approach, 50-g OGCT screening
followed by a 100-g 3-hour OGTT for screening positive patients.
The American Diabetes Association (ADA) supports use of either
a one-step or a two-step approach in 2015. The authors of “Dia-
betes mellitus in pregnancy: Screening and diagnosis (UpToDate,
Wolters Kluwer)” recommend a one-step testing, the same as
the IADPSG criteria. The latest guideline by the World Health Or-
ganization also recommends the use of a 75-g 2-hour OGTT for
GDM.
A diagnosis of GDM is made when one or more of the following
glucose thresholds are met: fasting 92e125 mg/dL, 1 hour
 180 mg/dL, or 2 hours ¼ 153e199 mg/dL. In contrast, a diagnosis
of “diabetes in pregnancy” is made if one or more of the followingby Elsevier Taiwan LLC. All rights reserved.
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2-hours plasma glucose level  200 mg/dL following a 75-g oral
glucose load, or random blood glucose level  200 mg/dL in the
presence of diabetes symptoms. The IADPSG and ADA criteria for
the diagnosis of overt diabetes are as follows: FPG level 126 mg/
dL or hemoglobin A1c (A1C) level 6.5%. A random plasma glucose
level  200 mg/dL is suggestive of overt diabetes; however, it
should be conﬁrmed with FPG or A1C.
According to the ADA criteria, the diagnostic thresholds for cat-
egories of increased risk for diabetes for adults (prediabetes) are as
follows: impaired fasting glucose if the FPG level 100e125 mg/dL
and IGT if the 2-hour plasma glucose level 140e199 mg/dL (using
a 75-g OGTT) or A1C ¼ 5.7e6.4% (the International Expert Commit-
tee recommended 6.0e6.4%). For a pregnant womanwith GDM, af-
ter childbirth a follow-up OGTT is recommended at 6e12 weeks
postpartum to test for diabetes or prediabetes if FPG levels <
126 mg/dL. In general, a 75-g OGTT can be performed by an inter-
nist, an endocrinologist, or a diabetologist. Women with prediabe-
tes or a normal OGTT should be counseled about their future risk of
developing diabetes as well as on the preventive interventions and
follow-up (such as rescreening interval). If diabetes mellitus (type
2) is diagnosed, transferring the patient under a specialist is highly
recommended.
Therefore, based on the foregoing discussion, I do not knowwhy
we as obstetricians insist on continuing the use of the traditional
100-g OGTT in pregnancy for the diagnosis of GDM and emphasize
on the comment or conclusion that using “the 100-g OGTT is neces-
sary” for improving pregnancy outcomes.
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